Angela J Luo, Lisa M Arkin, Sarah Asch, Latanya Benjamin, Anna L Bruckner, María Laura Cossio, Lucia Diaz, Evelyn Lilly, Erin F Mathes, Caroline A Nelson, Elena Pope, Sarika Ramachandran, Dawn H Siegel, Joyce M C Teng, Yunshan Xu, Yanhong Deng, Amy S Paller, Keith A Choate
{"title":"Reliability of the Ichthyosis Scoring System in Individuals With Skin of Color.","authors":"Angela J Luo, Lisa M Arkin, Sarah Asch, Latanya Benjamin, Anna L Bruckner, María Laura Cossio, Lucia Diaz, Evelyn Lilly, Erin F Mathes, Caroline A Nelson, Elena Pope, Sarika Ramachandran, Dawn H Siegel, Joyce M C Teng, Yunshan Xu, Yanhong Deng, Amy S Paller, Keith A Choate","doi":"10.1001/jamadermatol.2025.1965","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>The Ichthyosis Scoring System (ISS) is a reliable instrument for assessing ichthyosis severity. The ISS's performance in individuals with skin of color (ie, Fitzpatrick IV-VI skin types) remains unknown because it was initially assessed in individuals with Fitzpatrick I to III skin types.</p><p><strong>Objective: </strong>To assess the reliability of the ISS in individuals with Fitzpatrick IV to VI skin types.</p><p><strong>Design, setting, and participants: </strong>In this cross-sectional study, 14 dermatologists used the ISS to rate 94 test photographs, 47 from individuals with Fitzpatrick I to III skin types and 47 from individuals with Fitzpatrick IV to VI skin types. The professional photographs were obtained from the National Registry for Ichthyosis and Related Disorders, which enrolls participants with ichthyosis from referral centers, patient advocacy groups, and self-referral worldwide. Test photographs represented individuals of all phototypes with ichthyosis of all severities. Due to limited comprehensive, high-quality photography among individuals with Fitzpatrick IV to VI skin types, 4 body sites were chosen: upper back, legs, upper arm, and dorsal feet. From August to December 2023, dermatologists independently scored the same test photographs and were blinded to photographic groupings. Data were analyzed in March 2024.</p><p><strong>Main outcomes and measures: </strong>Interrater reliabilities were determined using interrater intraclass correlation coefficients (ICCs) using the two-way random effects model.</p><p><strong>Results: </strong>Of the 61 individuals with ichthyosis represented in the 94 photographs, 28 (46%) were younger than 18 years and 33 (54%) were 18 years and older; 32 (52%) were female and 29 (48%) were male; and 1 (2%) was American Indian, 16 (26%) were Black, 6 (10%) were Hispanic, 1 (2%) was Pacific Islander, 5 (8%) were South Asian, 31 (51%) were White, and 1 (2%) was White and Hispanic. For individuals with Fitzpatrick I to III skin types, scale and erythema ICCs ranged from 0.97 (95% CI, 0.93-0.99) to 0.99 (95% CI, 0.98-1.00) and 0.91 (95% CI, 0.79-0.97) to 0.95 (95% CI, 0.89-0.99), respectively. For individuals with Fitzpatrick IV to VI skin types, scale and erythema ICCs ranged from 0.97 (95% CI, 0.93-0.99) to 0.99 (95% CI, 0.98-1.00) and 0.90 (95% CI, 0.80-0.96) to 0.94 (95% CI, 0.86-0.98), respectively. The overlap of ICC confidence intervals demonstrates ISS reliability across phototypes.</p><p><strong>Conclusions and relevance: </strong>This cross-sectional study shows that the ISS can be applied across phototypes to measure ichthyosis severity. Further studies using full-body photographs would further bolster the ISS's reliability to assess global ichthyosis severity. These findings set the stage for increasing diversity in ichthyosis clinical trials.</p>","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":"849-854"},"PeriodicalIF":11.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242821/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamadermatol.2025.1965","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Importance: The Ichthyosis Scoring System (ISS) is a reliable instrument for assessing ichthyosis severity. The ISS's performance in individuals with skin of color (ie, Fitzpatrick IV-VI skin types) remains unknown because it was initially assessed in individuals with Fitzpatrick I to III skin types.
Objective: To assess the reliability of the ISS in individuals with Fitzpatrick IV to VI skin types.
Design, setting, and participants: In this cross-sectional study, 14 dermatologists used the ISS to rate 94 test photographs, 47 from individuals with Fitzpatrick I to III skin types and 47 from individuals with Fitzpatrick IV to VI skin types. The professional photographs were obtained from the National Registry for Ichthyosis and Related Disorders, which enrolls participants with ichthyosis from referral centers, patient advocacy groups, and self-referral worldwide. Test photographs represented individuals of all phototypes with ichthyosis of all severities. Due to limited comprehensive, high-quality photography among individuals with Fitzpatrick IV to VI skin types, 4 body sites were chosen: upper back, legs, upper arm, and dorsal feet. From August to December 2023, dermatologists independently scored the same test photographs and were blinded to photographic groupings. Data were analyzed in March 2024.
Main outcomes and measures: Interrater reliabilities were determined using interrater intraclass correlation coefficients (ICCs) using the two-way random effects model.
Results: Of the 61 individuals with ichthyosis represented in the 94 photographs, 28 (46%) were younger than 18 years and 33 (54%) were 18 years and older; 32 (52%) were female and 29 (48%) were male; and 1 (2%) was American Indian, 16 (26%) were Black, 6 (10%) were Hispanic, 1 (2%) was Pacific Islander, 5 (8%) were South Asian, 31 (51%) were White, and 1 (2%) was White and Hispanic. For individuals with Fitzpatrick I to III skin types, scale and erythema ICCs ranged from 0.97 (95% CI, 0.93-0.99) to 0.99 (95% CI, 0.98-1.00) and 0.91 (95% CI, 0.79-0.97) to 0.95 (95% CI, 0.89-0.99), respectively. For individuals with Fitzpatrick IV to VI skin types, scale and erythema ICCs ranged from 0.97 (95% CI, 0.93-0.99) to 0.99 (95% CI, 0.98-1.00) and 0.90 (95% CI, 0.80-0.96) to 0.94 (95% CI, 0.86-0.98), respectively. The overlap of ICC confidence intervals demonstrates ISS reliability across phototypes.
Conclusions and relevance: This cross-sectional study shows that the ISS can be applied across phototypes to measure ichthyosis severity. Further studies using full-body photographs would further bolster the ISS's reliability to assess global ichthyosis severity. These findings set the stage for increasing diversity in ichthyosis clinical trials.
期刊介绍:
JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery.
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. It is published online weekly, every Wednesday, and in 12 print/online issues a year. The mission of the journal is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, with the aim of enabling dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care.
The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. It also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists, aiming to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists.
JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.